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Uromodulin is expressed in the distal convoluted
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Uromodulin, the most abundant protein in normal urine, is
essentially produced by the cells lining the thick ascending
limb. There it regulates the activity of the cotransporter
NKCC2 and is involved in sodium chloride handling and
blood pressure regulation. Conﬂicting reports suggested
that uromodulin may also be expressed in the distal
convoluted tubule (DCT) where its role remains unknown.
Using microdissection studies combined with ﬂuorescent in
situ hybridization and co-immunostaining analyses, we
found a signiﬁcant expression of uromodulin in mouse and
human DCT at approximately 10% of thick ascending limb
expression levels, but restricted to the early part of the DCT
(DCT1). Genetic deletion of Umod in mouse was reﬂected
by a major shift in NCC activity from the DCT1 to the
downstream DCT2 segment, paralleled by a compensatory
expansion of DCT2. By increasing the distal sodium
chloride and calcium ion load with chronic furosemide
administration, an intrinsic compensatory defect in the DCT
from Umod-/- compared to wild type mice was found
manifested as sodium wasting and hypercalciuria. In line,
co-expression studies in HEK cells suggested a facilitating
role for uromodulin in NCC phosphorylation, possibly via
SPAK-OSR1 modulation. These experiments demonstrate a
signiﬁcant expression of uromodulin in the early part of
mouse and human DCT. Thus, biosynthesis of uromodulin
in the DCT1 is critical for its function, structure and
plasticity, suggesting novel links between uromodulin,
blood pressure control and risk of kidney stones.
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U romodulin, themost abundant protein in healthy urine,is exclusively expressed in the kidney,1 with transcrip-tion levels among the highest in this organ.2 Early
studies in mammalian species, including humans, established
that uromodulin is essentially synthesized in the epithelial cells
lining the thick ascending limb (TAL) of the loop of Henle.3,4
Uromodulin is a glycosylphosphatidylinositol–anchored pro-
tein targeted to the apical membrane, where it is cleaved by the
serine protease hepsin. In the lumen, uromodulin monomers
assemble via their zona pellucida domain to form a dense
matrix of high-molecular-weight polymers constituting the
hyaline casts.5 The biological importance of uromodulin is
supported by genetic evidence. Rare mutations in the UMOD
gene encoding uromodulin lead to defective trafﬁcking of
mutant uromodulin, with endoplasmic reticulum (ER) stress
causing autosomal dominant tubulointerstitial kidney dis-
ease.6,7 Genome-wide association studies have revealed that
common variants in the promoter of UMOD are associated
with the risk of chronic kidney disease, calcium stones, and
hypertension in the general population.8–10
The physiological roles of uromodulin, which have been
demonstrated in Umod/ mice, include protection against
intrarenal/tubular calcium oxalate crystallization11 and regu-
lation of the activity and surface abundance of the Naþ/Kþ/
2Cl- cotransporter NKCC2, and renal outer medullary po-
tassium channel ROMK in the TAL, hence the sodium avidity
and urinary concentrating ability of the kidney.12–14 The latter
hypothesis is supported by the fact that the UMOD variants
associated with hypertension drive higher uromodulin
expression and are accompanied by higher NKCC2 activity in
humans.15
If the TAL is established as the major site of uromodulin
production, there are conﬂicting reports about a potential
expression of uromodulin gene and protein in downstream
segments. Radio-labeled in situ hybridization detected Umod
mRNA signals in the rat TAL, with an abrupt ending at the
transition to the distal convoluted tubule (DCT).3 Consistent
with this ﬁnding, immunoﬂuorescent and electron micro-
scopy in rat kidney detected uromodulin only in TAL cells,
excepting the macula densa.16,17 In contrast, uromodulin
protein was reported in the DCTof hamster,18 rat,19 mouse,20
and human4 kidneys. However, these results were inconclu-
sive because the positive immunostaining signal could reﬂect
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luminal uromodulin adhering on the apical region of tubular
cells lining segments downstream of the production site in the
TAL. In fact, studies in human kidney showed that, in
contrast to the plasmalemmal and cytoplasmic staining for
uromodulin in TAL cells, only the very luminal plasmalemma
was stained in DCT cells.21 More recently, transcriptomic data
showed some level of uromodulin mRNA in the DCT
in mouse,22 rat,23 and human24 kidneys—again difﬁcult to
interpret owing to potential contamination by the very high
expression levels in adjacent TAL segments.
In this study we combined multilevel analyses of uromo-
dulin mRNA and protein expression along the TAL and the
DCT and in-depth testing of mouse models to demonstrate a
speciﬁc expression of uromodulin in the early part of the
DCT, with a distinct role in Naþ/Cl cotransporter (NCC)
activation and local electrolyte handling.
RESULTS
Localization of Umod transcripts by microdissection in rodent
kidney
We ﬁrst analyzed the abundance of Umod transcripts by
quantitative reverse transcription–polymerase chain reaction
(RT-qPCR) using well-characterized tubular segments of
mouse kidney obtained by microdissection.25 The highest
Umod transcript levels were detected in the TAL, followed by
the DCT that showedw10% of TAL expression levels (24.3 
3.4 vs. 2.1  0.8 in DCT; expressed as 2
ˇ
(CtGapdh-CtUmod) 
106). Umod transcripts were undetectable in proximal tubules
and collecting duct fractions (Figure 1a). We excluded
TAL contamination in DCT fractions by showing virtual
absence of Slc12a1f transcripts, encoding NKCC2F, the
most abundant isoform expressed in the outer medulla
(Figure 1b).26
We conﬁrmed the presence of Umod transcripts in a pure
DCT1 fraction by using ﬂuorescence-assisted microdissection.
The transgenic mouse line PV-EGFP expresses enhanced green
ﬂuorescence protein (EGFP) under the promoter of the Pvalb
gene, encoding parvalbumin selectively in DCT1 cells.27,28
Colocalization of EGFP with NCC conﬁrmed its localization
in DCT1 versus DCT2 segments (Figure 1ci, ii). Robust Umod
transcript levels were detected in pure DCT1 fractions, charac-
terized by virtually absent Slc12a1 (NKCC2) transcripts and
high levels of Slc12a3 (NCC) transcripts (Slc12a3: 5.2  0.6;
Umod: 1.4  0.3; Slc12a1: 0.001  0.0003; expressed as
Figure 1 | Localization of Umod transcripts by microdissection in rodent kidney. (a) Umod transcript levels in microdissected kidney
segments from C57BL/6J mice as assessed by quantitative reverse transcription–polymerase chain reaction (RT-qPCR). Levels are expressed
as 2
ˇ
(CtGapdh-CtUmod)  10
ˇ
6. Bars indicate average  SEM. n ¼ 3 fractions. (b) Slc12a1f transcript levels in microdissected mouse kidney
segments as assessed by RT-qPCR. Levels are expressed as 2
ˇ
(CtGapdh-CtSlc12a1f)  10
ˇ
6. Bars indicate average  SEM. n ¼ 3 fractions. (c) (i)
Representative immunoﬂuorescence staining of Naþ/Cl cotransporter (NCC, red) on parafﬁn-embedded kidney sections from PV-EGFP
mice.27,28 Arrows indicate NCC-positive, enhanced green ﬂuorescence protein (EGFP)-negative segments. Nuclei are counterstained with
40,6-diamidino-2-phenylindole (DAPI). (ii) Transition from a TAL segment (NCC-negative) to a DCT1 segment (NCC- and EGFP-positive) on a
parafﬁn-embedded kidney section from a PV-EGFP mouse. Nuclei are counterstained with DAPI. (iii) Transcript levels of indicated genes in DCT1
fractions obtained by ﬂuorescence-assisted microdissection on PV-EGFP kidneys. Levels are expressed as 2
ˇ
(CtGapdh-Cttarget genes)  10
ˇ
6. Bars
indicate average SEM. n ¼ 5 fractions. CD, collecting duct; DCT, distal convoluted tubule; G, glomerulus; PCT, proximal convoluted tubule; PST,
proximal straight tubule; TAL, thick ascending limb. To optimize viewing of this image, please see the online version of this article at www.
kidney-international.org.
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2ˇ
(CtGapdh-Cttarget gene) 10
ˇ
6) (Figure 1ciii). Analysis of open-
source transcriptomics databases conﬁrmed that Umod tran-
scripts in DCT accounted for 3.8% and 2.6% of cortical TAL
levels in CD1 mice and Sprague-Dawley rats, respectively
(Supplementary Figure S1A, B).22,23
Localization of Umod transcripts by in situ hybridization in
mouse kidney
Multiplex ﬂuorescent in situ hybridization probes were
designed for Umod, Slc12a1 (NKCC2), and Slc12a3 (NCC),
the speciﬁcity of the Umod probe being veriﬁed on Umod/
kidneys (Supplementary Figure S2). Hybridization on mouse
kidney revealed 2 clusters of Umod-positive tubules (green) in
the cortex, differing in their amount of Umod dots
(Figure 2a). The high Umod mRNA tubules (arrows) were
positive for Slc12a1 (red) and negative for Slc12a3 (cyan),
identifying them as TALs. In contrast, the low Umod mRNA
tubules (arrowheads) were negative for Slc12a1 (red) and
positive for Slc12a3 (cyan), identifying them as DCTs. No
Umod mRNA expression outside of TAL or DCT was detec-
ted. The distinct Umod mRNA expression patterns are clearly
visible in TAL (Figure 2b) and DCT (Figure 2c) segments,
with an abrupt transition in Umod mRNA abundance from
TAL to DCT1 (Figure 2d). Semi-automated quantiﬁcation of
ﬂuorescent dots, representing single Umod mRNA mole-
cules,29 indicated that an average DCT tubule expresses
w15% of the UmodmRNA expressed in a cortical TAL (138.6
 8.0 vs. 20.8  2.0 in DCT, arbitrary units representing dots
normalized to tubule area) (Figure 2e). This ﬁnding is in close
agreement with the expression values detected by RT-qPCR
on microdissected tubules.
Umod expression in TAL along the corticomedullary axis
An increasing body of evidence suggests the TAL being het-
erogeneous along the corticomedullary axis.30 Transcriptomics
data suggested higher Umod expression in cortical TAL (cTAL)
compared with medullary TAL (mTAL) in rodent kidney (1.4-
and 7.8-fold higher expression in mouse and rat cTAL,
respectively) (Supplementary Figure S1) and a trend in the
same direction in human kidney.24 Our analysis of mTAL and
cTAL fractions, validated by enrichment of splicing isoforms of
Slc12a1 (Figure 3a), revealed 1.5-fold higher Umod transcript
Figure 2 | Localization of Umod transcripts by in situ hybridization in mouse kidney. (a) Representative picture of ﬂuorescent multiplex in
situ hybridization (RNAscope) for Umod (green), Slc12a1 (red), and Slc12a3 (cyan) on cryosections from mouse kidney. Umod mRNA is
consistently detected in distal convoluted tubule (DCT) tubules (arrowheads), albeit at lower levels compared with cortical thick ascending limb
(cTAL) tubules (arrows). Nulcei are counterstained with 40,6-diamidino-2-phenylindole (DAPI). (b) High-magniﬁcation ﬂuorescent multiplex in
situ hybridization showing Umod mRNA in cTAL, as identiﬁed by positive Slc12a1 mRNA detection and absent Slc12a3 mRNA. Nuclei are
counterstained with DAPI. (c) High-magniﬁcation ﬂuorescent multiplex in situ hybridization showing Umod mRNA in DCT, as identiﬁed by
absent Slc12a1 mRNA and detection of Slc12a3 mRNA. Nulcei are counterstained with DAPI. (d) Fluorescent multiplex in situ hybridization
showing Umod mRNA at the transition from cTAL (arrow) to DCT (arrowhead). Nuclei are counterstained with DAPI. (e) Semi-automated
quantiﬁcation of Umod mRNA dots (representing single mRNA molecules29) normalized to tubule area in cTAL tubules (n ¼ 87) versus DCT
tubules (n ¼ 34); n ¼ 2 mice. Bars represent mean  SEM; ****P < 0.0001 (Unpaired 2-tailed t test). G, glomerulus. To optimize viewing of this
image, please see the online version of this article at www.kidney-international.org.
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levels in the cTAL compared with mTAL (41.2 3.2 vs. 27.0
2.6 in mTAL, expressed as 2
ˇ
(CtGapdh-CtUmod)  10
ˇ
6)
(Figure 3b). In situ hybridization showed a corticomedullary
gradient for Umod expression, with cortical TALs displaying a
stronger ﬂuorescent labeling compared withmTALs (Figure 3c,
d). Semi-automated quantiﬁcation of ﬂuorescent dots in-
dicates that an average cTAL (as deﬁned by close spatial relation
with a glomerulus) expresses roughly 1.6-fold the amount of
UmodmRNA expressed in mTAL (138.6 8.0 vs. 87.2 3.2 in
mTAL, arbitrary units representing dots normalized to tubule
area) (Figure 2e), similar to the RT-qPCR data.
Immunoﬂuorescent localization of uromodulin along the DCT
To investigate whether the Umod mRNA expression in DCT is
mirrored by uromodulin protein localization, we performed
immunoﬂuorescent stainings for uromodulin and NCC in
serial sections from mouse kidneys (Figure 4a). A cluster of
tubules displaying a signal for uromodulin (green) and for
NCC (red; arrowheads) was identiﬁed (Figure 4a, upper
panels). The uromodulin signal was weaker in the NCC-
positive tubules (DCT) compared with that observed in
TAL segments (Figure 4a, lower panels). Furthermore, a
consistent uromodulin expression was detected in EGFP-
expressing DCT1 tubules in sections from PV-EGFP mouse
kidneys, with conﬁrmation of different staining intensity
between TAL and DCT segments (Figure 4b). Confocal
imaging showed uromodulin located at the apical plasma
membrane in DCT1 tubules (arrow), similar to the TAL
distribution pattern (arrowhead) (Figure 4c).
Coimmunostaining for uromodulin (green) and NCC (red)
in human kidney conﬁrmed the partial overlap of
expression (arrow) (Figure 4d), in line with mRNA data.24
Uromodulin was also detected by immunoperoxidase in
parvalbumin-expressing human DCT1 (Figure 4e).
Because missense mutations in UMOD are causing an ER
accumulation of mutant uromodulin in autosomal dominant
tubulointerstitial kidney disease,6,7 we assessed whether uro-
modulin is also accumulating inside the DCT of the
UmodC125R/þ mouse model.7 Immunoﬂuorescent analyses
showed that, in addition to the TAL, uromodulin is
Figure 3 | Umod expression along the corticomedullary axis of the thick ascending limb (TAL). (a) Relative transcript levels of Slc12a1f and
Slc12a1b, as assessed by quantitative reverse transcription–polymerase chain reaction (RT-qPCR) in medullary TAL (mTAL) and cortical TAL
(cTAL) fractions isolated from mouse kidneys. Levels are expressed relative to corresponding enrichment marker. Bars indicate average  SEM.
n ¼ 2 to 3 fractions. (b) Umod transcript levels in microdissected nephron segments from mouse kidneys as assessed by RT-qPCR. Levels are
expressed as 2
ˇ
(CtGapdh-CtUmod)  10
ˇ
6. Bars indicate average  SEM. n ¼ 5 fractions. (c) Representative low-magniﬁcation ﬂuorescent
multiplex in situ hybridization (RNAscope) for Umod (green) on mouse kidney cryosections. Kidney borders indicated by white dashes. (d)
Representative ﬂuorescent multiplex in situ hybridization showing Umod mRNA in cTAL and mTAL on mouse kidney cryosections. Insets show
higher magniﬁcations of indicated cortical (upper panel) and medullary (lower panel) regions. Cortex is identiﬁed by the presence of glomeruli.
Nuclei are counterstained with 40,6-diamidino-2-phenylindole (DAPI). (e) Semi-automated quantiﬁcation of Umod mRNA dots (representing
single mRNA molecules29) normalized to tubule area in mTAL tubules (n ¼ 90) versus cTAL tubules (n ¼ 87). TAL tubules were identiﬁed
by positive Slc12a1 expression; cTAL identiﬁcation required the presence of a glomerulus in the same high-magniﬁcation ﬁeld. n ¼ 2 mice. Bars
indicate average  SEM. ****P < 0.0001 (unpaired 2-tailed t test). C, cortex; CCD, cortical collecting duct; CNT, connecting tubule; DCT, distal
convoluted tubule; IM, inner medulla; IS, inner stripe of the outer medulla; OMCD, outer medullary collecting duct; OS, outer stripe of the outer
medulla; PCT, proximal convoluted tubule; PST, proximal straight tubule. To optimize viewing of this image, please see the online version of this
article at www.kidney-international.org.
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accumulating in the cytoplasm of DCT cells in UmodC125R/þ
kidneys, contrasting with its apical expression in Umodþ/þ
mice (Figure 4f). These data provide more evidence for the
biosynthesis of uromodulin in the DCT.
Uromodulin expression is restricted to the DCT1 segment in
mouse kidney
The DCT is divided into the functionally distinct DCT1 and
downstream DCT2.31,32 A cluster of tubules identiﬁed as DCT
by in situ hybridization were devoid of Umod expression,
whereas others showed consistent Umod expression
(Figure 5a). Furthermore, some DCTs in the UmodC125R/þ
kidneys were not accumulating uromodulin (Figure 4f). To
assess whether uromodulin expression is restricted to DCT1,
we performed a triple staining with uromodulin (green),
NCC (cyan), and parvalbumin (red) (Figure 5b). The DCT1
sections were deﬁned as NCC- and parvalbumin-positive,
whereas NCC-positive and parvalbumin-negative tubules
were deﬁned as DCT2. A strong expression gradient for
uromodulin was quantiﬁed along the DCT, with DCT2
expression intensity being w15% of that detected in DCT1
(DCT2: 14.9%  2.4% of DCT1 uromodulin expression,
assessed as uromodulin ﬂuorescent intensity normalized to
tubule area) (Figure 5c). In line with this ﬁnding, ﬂuorescent
costaining analyses between uromodulin and TRPV5
(ECaC1), an apical Ca2þ channel expressed in the DCT2 and
the downstream connecting tubule but not in DCT1,32
showed no signiﬁcant co-distribution (Figure 5d). These
data show that a signiﬁcant expression of uromodulin is also
detected in the DCT, being largely restricted to the initial
portion of that segment (DCT1). Uromodulin is not detected
elsewhere than in the TAL and DCT.
Structural effects of uromodulin in mouse DCT
The DCT is critical for the transcellular reabsorption of NaCl,
mediated by NCC, and the ﬁne-tuning of urinary Ca2þ and
Mg2þ excretion.31 Absence of uromodulin in Umod/ mice
is known to affect apical transport systems in the TAL,
causing adaptations in the DCT (i.e., NCC hyperactivation
and DCT hypertrophy).12 To substantiate our ﬁndings of
uromodulin expression in DCT1, we dissected direct effects of
uromodulin on DCT function from secondary compensatory
Figure 4 | Immunoﬂuorescent localization of uromodulin along the distal convoluted tubule (DCT). (a) Upper panels: Representative
immunoﬂuorescence staining for uromodulin (green) and Naþ/Cl cotransporter (NCC, red) on serial parafﬁn-embedded sections from mouse
kidney, showing consistent but weaker staining of uromodulin in NCC-positive tubules (arrowheads) compared with putative thick ascending
limbs (TALs) (arrows). Lower panels: Higher magniﬁcation of a transition from a TAL to an NCC-positive DCT1 and highlighting the accom-
panying decrease in uromodulin intensity. Nuclei are counterstained with 40,6-diamidino-2-phenylindole (DAPI). (b) Representative immuno-
ﬂuorescence staining for uromodulin (red) on parafﬁn-embedded kidney sections from PVALB-EGFP mice, conﬁrming consistent but weaker
staining of uromodulin in enhanced green ﬂuorescent protein (EGFP, green) positive DCT1 tubules. (c) Apical localization of uromodulin (red) in
DCT1, as shown on immunoﬂuorescent confocal imaging on parafﬁn-embedded PVALB-EGFP kidneys (arrow). A putative TAL is shown for
comparison (arrowhead). Nuclei are counterstained with DAPI. (d) Representative immunoﬂuorescence staining for uromodulin (green) and
NCC (red) on parafﬁn-embedded sections from normal human kidney showing partial overlap of signal (arrow). (e) Immunoperoxidase labeling
for uromodulin and parvalbumin on normal human kidney serial sections showing partial overlap of signal in DCT1. (Continued)
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mechanisms by using a chronic (5-day) furosemide treatment
coupled with acute hydrochlorothiazide (HCTZ) adminis-
tration in Umod/ and Umodþ/þ mice.
At baseline, Umod/ mice showed a slight increase in
total NCC expression in total kidney membranes, in line
with previous report.12 The phosphorylated NCC (pNCC)
(at T53 and T58) were both increased, reﬂecting w1.5-fold
increased pNCC/total NCC ratios in Umod/ compared
with Umodþ/þ mice (Figure 6a, b). Chronic furosemide
infusion, which increases distal Naþ delivery and triggers
DCT activity,33 led to a dramatic increase of total and
phosphorylated NCC in both groups (þ270% vs. 284% for
total NCC; þ978% vs. þ1063% for T53 pNCC; and þ685%
vs. þ675% for T58 pNCC in Umodþ/þ and Umod/ mice,
respectively, relative to Umodþ/þ baseline levels) (Figure 6a,
b). Although the absolute levels of total NCC and pNCC
were similar between the 2 genotypes after furosemide, the
fold change of pNCC (between baseline and furosemide
infusion) was markedly reduced in Umod/ mice
(Figure 6c).
Because uromodulin is mostly expressed in DCT1, we
investigated the relative contribution of DCT1 versus DCT2 in
the changes observed. Immunostaining revealed a w2-fold
decrease of T53 pNCC in DCT1 tubules of Umod/ versus
Umodþ/þ mice at baseline (14.0  0.9 vs. 25.6  1.2, respec-
tively; P < 0.0001; arbitrary units of ﬂuorescent intensity per
tubule area), paralleled by stronger T53 pNCC inDCT2 (20.8
0.9 vs. 14.6  0.7 respectively; P < 0.0001) (Figure 6d [upper
panels] and Figure 6e [left panels]). Chronic furosemide
infusion equalized the T53 pNCC signals in the DCT1 (28.1
1.4 vs. 29.9 1.4, respectively), whereas T53 pNCCwas further
increased in DCT2 of Umod/ versus Umodþ/þmice (33.4 
1.8 vs. 18.6  1.7, respectively; P < 0.0001) (Figure 6d [lower
panels] and Figure 6e [right panels]).
To detect structural adaptations, we investigated the renal
fractional volume occupied by T53 pNCC-positive DCT1
versus DCT2 segments (Supplementary Figure S3).34 At
baseline the renal fractional volume occupied by pNCC-
positive DCT1 was slightly lower in Umod/ versus
Umodþ/þ mice (1.6%  0.2% vs. 2.0%  0.2% of renal
volume, respectively; P ¼ 0.09). Conversely, the renal frac-
tional volume occupied by pNCC-positive DCT2 was higher
in Umod/ versus Umodþ/þ mice (3.5%  0.4% vs. 1.5% 
0.2% of renal volume, respectively; P< 0.001) (Figure 6f, left
panels), in line with quantiﬁcation data based on TRPV5
stainings (Supplementary Figure S4B). After chronic furose-
mide infusion, the renal fractional volume occupied by
pNCC-positive DCT1 was signiﬁcantly lower in Umod/
versus Umodþ/þ mice (2.1%  0.3% vs. 3.2  0.3% of renal
volume, respectively; P ¼ 0.015), whereas the renal fractional
volume occupied by pNCC-positive DCT2 was higher (3.7%
 0.3% vs. 2.5%  0.4% of renal volume, respectively; P ¼
0.025) (Figure 6f, right panel), also in line with TRPV5
staining data (Supplementary Figure S4B). Although chronic
furosemide infusion triggers a signiﬁcant compensatory in-
crease in DCT1 and DCT2 fractional volume in Umodþ/þ
mice, this response is markedly blunted in Umod/ mice
(Figure 6f, right panel; Supplementary Figure S4).
Figure 4 | (Continued) (f) Representative immunoﬂuorescence staining for uromodulin (green) and NCC (red) on parafﬁn-embedded kidney
sections from Umodþ/þ and UmodC125R/þ mice. Nuclei are counterstained with DAPI. G, glomerulus. To optimize viewing of this image, please
see the online version of this article at www.kidney-international.org.
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Functional effects of uromodulin in the mouse DCT
To test the DCT function at baseline and in the situation of
increased NaCl delivery, we monitored NaCl, as well as Ca2þ
andMg2þ handling, after acute HCTZ injection at baseline and
after chronic furosemide treatment in mice. The parameters of
Umod/ and Umodþ/þ mice were similar at baseline or after
vehicle (0.9% NaCl) injection (Tables 1 and 2; Supplementary
Table S1). Chronic furosemide infusion led to a slight urinary
Naþwasting inUmod/ but not inUmodþ/þmice (Figure 7ai,
Table 2; Supplementary Figure S5A), suggesting impaired distal
tubular compensatory mechanisms. Acute HCTZ
administration led to an exaggerated natriuretic response in
Umod/ mice, conﬁrming NCC hyperactivation (Figure 7aii,
Table 1). HCTZ injection after the 5-day furosemide infusion
revealed a signiﬁcantly attenuated natriuretic response in
Umod/ versus Umodþ/þ mice (Figure 7aii, Table 3), more
evident when considering the fold change in HCTZ-induced
natriuria between furosemide-infusion and control condi-
tions (Figure 7aiii).
Chronic furosemide infusion yielded excessive urinary
calcium wasting in Umod/ versus Umodþ/þ mice, evident
after 3–5 days of treatment (Figure 7bi, Table 2) and also
Figure 5 | Uromodulin expression is restricted to the early distal convoluted tubule (DCT1) segment. (a) Representative picture of
ﬂuorescent multiplex in situ hybridization (RNAscope) for Umod (green) and Slc12a3 (cyan) on mouse kidney cryosections. A cluster of DCTs
expressing Slc12a3 is devoid of Umod mRNA (asterisk), in contrast to others abundantly expressing Umod (arrowheads). (b) Representative triple
immunoﬂuorescence staining for uromodulin (green), Naþ/Cl cotransporter (NCC, cyan), and parvalbumin (red) on parafﬁn-embedded kidney
section showing segments of thick ascending limb (TAL) (asterisk), DCT1 (arrows), and DCT2 (arrowheads). (c) Quantiﬁcation of uromodulin
signal intensity in DCT1 and DCT2. The quantiﬁcation is based on 79 DCT1 and 39 DCT2 segments from 15 distinct ﬁelds from 3 different mice.
Results are expressed in arbitrary units representing uromodulin ﬂuorescent intensity normalized to tubule area and to DCT1. Bars indicate
average  SEM. n ¼ 3 mice. ****P < 0.0001 (unpaired 2-tailed t test). (d) Representative immunoﬂuorescence staining for uromodulin (green)
and TRPV5 (ECaC1, red) on parafﬁn-embedded kidney section, showing segments of DCT2/connecting tubule with absent uromodulin
expression (arrowheads). G, glomerulus. To optimize viewing of this image, please see the online version of this article at www.kidney-
international.org.
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revealed by day-5 versus day-1 comparisons (Supplementary
Figure S5B). Because the rate-limiting step for transcellular
Ca2þ uptake in the DCT2 is the Ca2þ channel TRPV5, we
investigated potential differences in its expression levels.
Similar levels of apical TRPV5 were observed in both Umodþ/þ
and Umod/ kidneys, both at baseline and after furosemide
infusion (Supplementary Figure S5C,D). Acute HCTZ injec-
tion reduced calciuria to a similar degree, whereas HCTZ
treatment after furosemide infusion yielded a similar response
in both genotypes (Figure 7bii, Tables 1 and 3). Urinary
Figure 6 | Structural effects of uromodulin in the mouse distal convoluted tubule (DCT). (a) Western blot analysis for indicated (phospho)-
proteins on kidney membrane fractions from Umodþ/þ and Umod/ mice, at baseline or after 5-day furosemide infusion (75 mg/g body weight
[gBW]/d). Short and long exposure times are shown, as indicated. Flotillin-1 is shown as a loading control. (b) Quantiﬁcation of Western blot
signal intensities, relative to expression in Umodþ/þ at baseline. Bars indicate average  SEM. Unpaired 2-tailed t test, Umod/ versus Umodþ/þ:
*P < 0.05; **P < 0.01; unpaired 2-tailed t test at baseline versus after furosemide (Furo): #P < 0.05; ##P < 0.01; ###P < 0.001; ####P < 0.0001. (c)
Quantiﬁcation of Western blot signal intensities, in fold increase of phosphorylated NCC (pNCC) signal between baseline and furosemide
infusion in Umodþ/þ and Umod/ mice. Bars indicate average  SEM. Unpaired 2-tailed t test, Umod/ versus Umodþ/þ: ***P < 0.001. (d)
Representative immunoﬂuorescence staining for T53 pNCC (red) and parvalbumin (green) on parafﬁn-embedded kidney sections from Umodþ/þ
and Umod/ mice, at baseline or after 5-day furosemide infusion (75 mg/gBW/d). Insets show zoom-ins on single tubules. (e) Quantiﬁcation of
T53 pNCC signal intensity in DCT1 (parvalbumin-positive) and DCT2 (parvalbumin-negative) segments from Umodþ/þ and Umod/ mice, at
baseline or after 5-day furosemide infusion (75 mg/gBW/d). Each parameter was quantiﬁed from at least 5 microscopic ﬁelds from at least 3
mice per genotype (at least 15 ﬁelds per genotype). Results are expressed in arbitrary units representing uromodulin ﬂuorescent intensity
normalized to tubule area. Each dot represents a tubule. Bars indicate average  SEM. Unpaired 2-tailed t test. Umod/ versus Umodþ/þ:
****P < 0.0001. (f) Left panel: Renal fractional volume (% of total kidney section) occupied by DCT1 or DCT2 segments, as identiﬁed by positive
T53 pNCC and positive or negative parvalbumine staining, respectively, in Umodþ/þ and Umod/ mice, at baseline. Bars indicate average 
SEM. n ¼ 9 low-magniﬁcation ﬁelds from 3 mice. Unpaired 2-tailed t test Umod/ versus Umodþ/þ: ***P < 0.001. Right panel: Renal fractional
volume (% of total kidney section) occupied by DCT1 or DCT2 segments, as identiﬁed by positive T53 pNCC and positive or negative par-
valbumine staining, respectively, in Umodþ/þ and Umod/ mice, after a 5-day furosemide infusion (75 mg/gBW/d). Bars indicate average 
SEM. n ¼ 9 low-magniﬁcation ﬁelds from 3 mice. Unpaired 2-tailed t test Umod/ versus Umodþ/þ: *P < 0.05; unpaired 2-tailed t test at
baseline versus after furosemide: #P < 0.05; ##P < 0.01. To optimize viewing of this image, please see the online version of this article at www.
kidney-international.org.
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magnesium excretion was similar in both genotypes, both at
baseline and after acute HCTZ and chronic furosemide
administration (Tables 1 and 2). Taken together, the func-
tional tests support a speciﬁc role for uromodulin in the DCT,
as chieﬂy evidenced by a defective response to furosemide-
induced increase in NaCl delivery.
Uromodulin facilitates NCC phosphorylation in vitro
To investigate the effects of uromodulin on NCC phosphor-
ylation, we used human embryonic kidney (HEK) cells stably
expressing human uromodulin (hUMOD).35 Transient
transfection of human NCC in these hUMOD-expressing
HEK cells and control HEK cells resulted in NCC protein
expression, as shown by speciﬁc bands at the expected mo-
lecular weight of w130 kDa above an aspeciﬁc band at 100
kDa, which is also present in mock-transfected cell lysates
(Figure 8a). Analysis of the ratio of phosphorylated (at T55
and T60, corresponding to mouse T53 and T58) versus total
NCC revealed a marked increase of the phosphorylated NCC
in hUMOD-expressing HEK cells compared with control
HEK cells (Figure 8b, c), suggesting a facilitating effect of
uromodulin on NCC maturation and phosphorylation
in vitro.
Phosphorylation of NCC is mediated by the WNK-SPAK/
OSR1 pathway.36 Immunoblotting of total kidney extracts
revealed reduced levels of pSPAK/pOSR1 in Umod/ versus
Umodþ/þ mice (Supplementary Figure S6A–C). Immuno-
staining for pSPAK/pOSR1 was detected in DCT1 segments in
Umodþ/þ kidneys, contrasting with a sharp transition and
nearly undetectable signal in the DCT1 segments in Umod/
kidneys (Supplementary Figure S6D).
DISCUSSION
Our studies demonstrate that uromodulin is expressed in the
initial part of the distal convoluted tube (DCT1) in mouse
and human kidney, along with peak levels in the cortical TAL.
We show that the lack of uromodulin is associated with
decreased pNCC in the DCT1, compensated by a stonger and
broader expression of pNCC in the DCT2, suggesting a shift
of NaCl uptake from DCT1 to downstream DCT2. The
functional relevance of these changes in the DCT is further
evidenced during chronic furosemide administration:
increased distal delivery of NaCl and Ca2þ leads to sodium
wasting and uncompensated hypercalciuria in Umod/ mice
compared with Umodþ/þ mice. These results suggest that the
biosynthesis of uromodulin is relevant for the role of the DCT
in NaCl and calcium homeostasis.
On the basis of its biochemical properties and capacity to
form a hydrophobic gel-like structure, uromodulin has been
associated for decades with the watertight property of the TAL
Table 1 | Urine and physiological parameters in UmodL/L and UmodD/D mice after acute hydrochlorothiazide (HCTZ) treatment
Parameter
Control HCTZ
UmodD/D UmodL/L n UmodD/D UmodL/L n
Body weight (BW; g) 30.1  0.5 29.9  1.1 5/5 29.6  0.5 29.1  0.8 5/5
Water intake (ml/min*gBW) 0.147  0.012 0.150  0.019 5/5 0.154  0.011 0.135  0.022 5/5
Diuresis (ml/min*gBW) 0.057  0.031 0.061  0.010 5/5 0.065  0.006 0.103  0.019 5/5
Urinary Naþ (mol/mol creat) 28.8  1.2 27.3  2.5 5/5 35.9  5.0 50.1  2.9##* 5/5
Urinary Cl (mol/mol creat) 48.8  2.8 54.5  4.0 5/5 53.9  6.5 72.1  2.7#* 5/5
Urinary Kþ (mol/mol creat) 71.6  2.6 78.8  8.2 5/5 67.3  4.7 75.3  3.3 5/5
Urinary Ca2þ (mol/mol creat) 0.63  0.14 0.59  0.15 5/5 0.27  0.03 0.38  0.04 5/5
Urinary Mg2þ (mol/mol creat) 4.8  0.2 4.9  0.7 5/5 4.4  0.4 5.3  0.2 5/5
creat, creatinine; HCTZ, hydrochlorothiazide; n, number of mice (male, 3 months).
Values represent means  SEM. Control: 0.9% NaCl 10 ml/g body weight (gBW), i.p., 6-hour urine collection; HCTZ: hydrochlorothiazide 50 mg/gBW, i.p., 6-hour urine collection.
Unpaired 2-tailed t test, Umod/ versus Umodþ/þ: *P < 0.05.
Paired 2-tailed t test, control versus HCTZ: #P < 0.05; ##P < 0.01.
Table 2 | Urine and physiological parameters in Umod-/- and UmodD/D mice after chronic furosemide treatment
Parameter
Baseline Chronic furosemide
UmodD/D UmodL/L n UmodD/D UmodL/L n
Body weight (BW; g) 25.4  1.2 27.6  0.6 8/8 26.2  0.7 28.4  0.4#* 4/4
Water intake (ml/min*gBW) 0.146  0.010 0.159  0.008 8/8 0.244  0.010## 0.368  0.017##*** 4/4
Diuresis (ml/min*gBW) 0.069  0.003 0.072  0.006 5/5 0.126  0.015# 0.213  0.035# 4/4
Urinary Naþ (mol/mol creat) 26.4  3.1 21.1  1.0 8/8 28.8  1.0 33.9  3.7# 4/4
Urinary Cl (mol/mol creat) 49.7  3.4 44.5  2.8 8/8 45.5  0.7 48.5  3.6 4/4
Urinary Kþ (mol/mol creat) 74.0  5.0 68.6  3.2 8/8 74.9  2.3 77.0  3.8# 4/4
Urinary Ca2þ (mol/mol creat) 0.32  0.04 0.26  0.03 8/8 0.76  0.04### 1.36  0.13##** 4/4
Urinary Mg2þ (mol/mol creat) 4.1  0.1 4.2  0.1 8/8 5.6  0.3## 5.5  0.2# 4/4
Creat, creatinine; n, number of mice (males, 3 months).
Values represent means  SEM. Baseline: average of two 16-hour overnight urine collections. Chronic furosemide: 75 mg/gBW/d for 5 days. Day-5 data are reported.
Unpaired 2-tailed t test, Umod/ versus Umodþ/þ: *P < 0.05; **P < 0.01; ***P < 0.001.
Paired 2-tailed t test, baseline versus furosemide day 5: #P < 0.05; ##P < 0.01; ###P < 0.001.
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and the urinary concentrating ability of the placental mam-
mals.5,37 Our ﬁnding of highest Umod expression in the
cortical TAL, conﬁrming previous reports,3,22,23 and the
robust expression of Umod in the DCT1 is at odds with a
primary role of uromodulin in establishing and/or conserving
the medullary osmolarity gradient. Considering the remark-
able abundance of uromodulin transcripts, which correspond
tow5% of the poly(A)þ mRNA from human kidney1 and to
w5% of the total rat cTAL transcriptome,23 the levels of
uromodulin expression detected in DCT1—corresponding to
10%–15% of that in the TAL—are far from being negligible.
The expression pattern of uromodulin (cTAL > mTAL >
DCT1) is likely to reﬂect speciﬁc functions in these special-
ized epithelia, complementing its role in the lumen.
Because the DCT reabsorbs NaCl and divalent cations,31 it
is tempting to speculate that uromodulin may play a role in
these processes. Previous studies were inconclusive for a
direct role of uromodulin in DCT, because baseline studies
Figure 7 | Functional effects of uromodulin in the mouse DCT. (a) Urinary sodium/creatinine (Naþ/Creat) at baseline and after functional
testing: (i) Evolution of urinary Naþ/Creat (mol/mol) from baseline to day 1, day 3, and day 5 of furosemide (Furo) infusion (75 mg/g body weight
[gBW]/d) in Umod/ and Umodþ/þ mice. Bars indicate average  SEM. n ¼ 8 at baseline and 4 during furosemide treatment. Paired 2-tailed t
test baseline versus furosemide infusion: #P < 0.05. (ii) Urinary Naþ/Creat (mol/mol) after i.p. injection of 0.9% NaCl versus a single i.p. injection
of 50 mg/gBW hydrochlorothiazide (HCTZ) in untreated mice or after 5 days of furosemide infusion in Umod/ and Umodþ/þmice, as indicated.
Bars indicate average  SEM. n ¼ 5. Paired 2-tailed t test HCTZ versus control or furosemide infusion plus HCTZ versus furosemide infusion:
##P < 0.01; ###P < 0.001; unpaired 2-tailed t test Umod/ versus Umodþ/þ: *P # 0.05. (iii) Fold change in urinary Naþ/Creat (mol/mol) after a
single i.p. injection of 50 mg/gBW HCTZ in day-5 furosemide-infused Umod/ and Umodþ/þ mice versus a single i.p. injection of 50 mg/gBW
HCTZ in untreated mice. Bars indicate average  SEM. Unpaired 2-tailed t test. Umod/ versus Umodþ/þ: *P < 0.05. (b) Urinary calcium/
creatinine (Ca2þ/Creat) at baseline and after functional testing: (i) Evolution of urinary Ca2þ/Creat (mol/mol) from baseline to day 1, day 3, and
day 5 of furosemide infusion (75 mg/gBW/d) in Umod/ and Umodþ/þ mice. Bars indicate average  SEM. n ¼ 8 at baseline and 4 during
furosemide treatment. Paired 2-tailed t test, baseline versus furosemide-infusion: ##P < 0.01; ###P < 0.001; unpaired 2-tailed t test, Umod/
versus Umodþ/þ: **P < 0.01. (ii) Urinary Ca2þ/Creat (mol/mol) after i.p. injection of 0.9% NaCl, after a single i.p. injection of 50 mg/gBW HCTZ in
untreated mice or after 5 days of furosemide infusion in Umod/ and Umodþ/þ mice. Bars indicate average  SEM. n ¼ 5.
Table 3 | Urine and physiological parameters in Umod-/- and UmodD/D mice after the acute addition of hydrochlorothiazide to
chronic furosemide treatment
Parameter
Chronic furosemide Chronic furosemide D HCTZ
UmodD/D UmodL/L n UmodD/D UmodL/L n
Body weight (BW; g) 29.9  0.6 31.6  1.0 5/5 30.5  0.5 29.6  1.3 5/5
Water intake (ml/min*gBW) 0.240  0.019 0.266  0.021 5/5 0.306  0.027 0.315  0.035 5/5
Diuresis (ml/min*gBW) 0.148  0.010 0.150  0.014 5/5 0.224  0.015## 0.214  0.019 5/5
Urinary Naþ (mol/mol creat) 21.9  1.3 27.1  2.2 5/5 106.2  10.2## 80.9  4.9### 5/5
Urinary Cl (mol/mol creat) 34.4  2.7 44.4  1.9* 5/5 116.7  7.0### 99.1  5.9## 5/5
Urinary Kþ (mol/mol creat) 57.9  2.3 68.9  3.7* 5/5 73.5  3.1### 78.0  0.8 5/5
Urinary Ca2þ (mol/mol creat) 0.86  0.07 1.05  0.04* 5/5 0.96  0.12 1.26  0.07 5/5
Urinary Mg2þ (mol/mol creat) 5.3  0.2 5.5  0.1 5/5 4.4  0.4## 5.2  0.3 5/5
HCTZ, hydrochlorothiazide; creat, creatinine; n, number of mice (male, 3 months).
Values represent means  SEM. Chronic furosemide: 75 mg/gBW/d during 5 days; day-5 data are reported. Chronic furosemide plus HCTZ: HCTZ 50 mg/gBW, i.p., administered
on day 5 of chronic furosemide, 6-hour urine collection.
Unpaired 2-tailed t test, Umod/ versus Umodþ/þ: *P < 0.05.
Paired 2-tailed t test chronic furosemide versus chronic furosemide plus HCTZ: ##P < 0.01; ###P < 0.001.
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and thiazide testing are unable to discriminate between
compensatory mechanisms due to chronic TAL dysfunction
and direct consequences of uromodulin deﬁciency in DCT.
The chronic inactivation of NKCC2 by furosemide infusion
not only eliminates any difference in NKCC2 activity but also
tests the ability of the DCT to compensate for increased distal
delivery of NaCl and divalent cations. Using this test com-
bined with immunoﬂuorescence quantiﬁcation, we could
demonstrate for the ﬁrst time that uromodulin activates NCC
in the DCT1, a role that is reﬂected by sodium wasting and a
blunted response to HCTZ and a defective ability to
compensate renal Ca2þ losses in Umod/ mice.
The mechanism by which uromodulin regulates NCC
activation is unclear and will require dedicated in vitro in-
vestigations. On the basis of the close homology between the
cotransporters,38 one could hypothesize that mechanisms
similar to those reported for NKCC2 could operate. It is
currently unclear how uromodulin modulates the activity of
NKCC2; previous studies incriminated the SPAK/OSR1
pathway,15 tumor necrosis factor-a signaling,14 or modula-
tions of intracellular Cl levels.12 Alternatively, luminal uro-
modulin might stabilize NCC in its activated form in the
DCT1, in absence of intracellular effects, as was previously
reported for TRPV5.39 However, this would not explain the
redistribution of phosphorylated NCC toward more distal
DCT segments and the increased pNCC levels that are found
in Umod/ mice at baseline. Our results suggesting that
uromodulin facilitates NCC phosphorylation in stably
transfected HEK cells support a cell-autonomous mechanism
involving posttranslational modiﬁcations rather than tran-
scriptional changes in Slc12a3. The evidence of strongly
reduced pSPAK/pOSR1 levels in the DCT1 of Umod/ mice
suggests a possible involvement of the WNK-SPAK/OSR1
pathway in this local regulation.
Regarding the inappropriate urinary Ca2þ losses in
Umod/ mice under furosemide, we detected no differences
in TRPV5 expression in Umodþ/þ and Umod/ kidneys,
ruling out a problem of apical Ca2þ entry. Instead, the urine
Ca2þ losses could be due to the shift of NaCl reabsorption to
DCT2 segments, responsible for Ca2þ uptake. In this setting,
the basolateral Naþ/Ca2þ exchanger NCX might function as
Naþ export system, thus increasing intracellular Ca2þ levels
and impairing Ca2þ uptake in DCT2. This hypothesis is
supported by the fact that the hypercalciuria of furosemide-
infused Umod/ mice was no longer in evidence after
HCTZ administration. The hypercalciuria that is observed in
pseudohypoaldosteronism type II patients with constitutive
activation of NCC could be mediated by similar
mechanisms.40
The demonstration that uromodulin regulates NCC in the
DCT, together with the previously described effect on
NKCC2,12,15 entails potential clinical implications. Both
NKCC2 and NCC are involved in recessive genetic disorders
leading to salt wasting and hypotension,41 whereas the carrier
status of loss-of-functions mutations in either SLC12A1 or
SLC12A3 is associated with reduced blood pressure in the
population.42 The expression levels of uromodulin directly
affect blood pressure control in mice, via NKCC2-mediated
NaCl handling in the TAL.14,15 In humans, common vari-
ants in the UMOD promoter that are associated with reduced
expression of uromodulin were associated with a reduced risk
for arterial hypertension and cardiovascular events.10
Conversely, carriers of UMOD promoter variants driving
higher uromodulin expression are more responsive to
Figure 8 | Uromodulin facilitates NaD/ClL cotransporter (NCC) phosphorylation in vitro. (a) Representative Western blot analysis for total
NCC and uromodulin in whole cell lysates from human embryonic kidney (HEK) cells stably expressing human uromodulin (hUMOD) or control
non–hUMOD-expressing HEK cells, either transiently transfected with human NCC (hNCC, 3 days after transfection) or mock-transfected, as
indicated. b-actin is shown as a loading control. *Aspeciﬁc band atw100 kDa, also identiﬁed in control cells that are mock-transfected and thus
do not express hNCC. (b) Western blot analysis for T55 (corresponding to murine T53) phosphorylated NCC (pNCC), T60 (corresponding to
mouse T58) pNCC, total NCC, and uromodulin in total cell lysates from hUMOD-expressing HEK cells and control non–hUMOD-expressing HEK
cells transiently transfected with human NCC (hNCC). b-actin is shown as a loading control. *Aspeciﬁc band. (c) Quantiﬁcation of Western blot
signal intensity ratios of pNCC (T55 and T60) over total NCC in hUMOD-expressing HEK cells relative to control non–hUMOD-expressing HEK
cells. Bars indicate average  SEM. Unpaired 2-tailed t test, hUMOD-expressing cells versus control HEK cells: *P < 0.05; ***P < 0.001. To
optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
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furosemide treatment in terms of natriuresis and blood
pressure decrease.15 Our ﬁndings raise questions regarding
the role of uromodulin in NCC-mediated NaCl and blood
pressure control and the modulation of thiazide response.
The altered Ca2þ handling in Umod/ mice suggests a role
for uromodulin in Ca2þ homeostasis, also supported by the
independent association of uromodulin excretion with uri-
nary Ca2þ excretion in population cohorts.43
Converging studies indicate a substantial plasticity of the
DCT. Increased distal NaCl delivery induced by chronic
furosemide treatment was followed by an expansion of the
DCT area in rats,33 whereas genetic deletion of NCC resulted
in marked hypoplasia of the early DCT.44 Elegant studies by
Lalioti et al.45 demonstrated that the DCT plasticity was
essentially driven by the activity of NCC, with corresponding
alterations in electrolyte and blood pressure control. The
DCT hypertrophy observed in rats was shown to be related to
increased DNA synthesis and cellular proliferation,46 but
precise mechanisms underlying this plasticity remain un-
known. Our data support a role for uromodulin in the
functional heterogeneity along the DCT: Umod/ mice show
less pNCC in DCT1 and increased pNCC in DCT2, paralleled
by an expansion of DCT2. When exposed to chronic distal
salt loading (furosemide), Umod/ mice show a severely
blunted capacity to increase NCC phosphorylation and lack
the capacity to upregulate the DCT1 and DCT2 areas,
compared with Umodþ/þ mice. Whether these structural
changes result from the lack of uromodulin acting as a trophic
factor for the DCT1 or reﬂect changes in NCC activity re-
quires further investigations.
In conclusion, our studies uncover a new role for uro-
modulin, in a new kidney tubular segment. In view of the
central homeostatic role of the DCT, intriguing questions
include the potential contribution of the DCT in the associ-
ation of UMOD variants with chronic kidney disease and
hypertension and in rare diseases caused by mutations in
UMOD.
MATERIALS AND METHODS
Animals
For expression analysis, 8–12-week-old C57BL6J male mice pur-
chased from Charles River (L’Arbresle, France), mice expressing
EGFP under the control of Pvalb gene promoter,27,28 and mice
heterozygous for the C125R Umod mutation7 were used. Umodþ/þ
and Umod/ mice (FVB background) were used for metabolic
studies. All mice were maintained in 12-hour light–dark cycles with
ad libitum water and standard laboratory diet before experiments.
For chronic NKCC2 inhibition, mice were anesthetized with iso-
ﬂurane (3%–5% in oxygen) and osmotic mini-pumps 2001 (Alzet,
Palo Alto, CA), ﬁlled with furosemide (Sigma, St. Louis, MO) (75
mg/g body weight [gBW]/d) dissolved in 50% dimethylsulfoxide/
0.9% NaCl (pH 8.0) were subcutaneously inserted in the inter-
scapular region. Osmotic pumps were incubated overnight at 37C
in 0.9% NaCl solution before implantation. All animal experiments
were performed in accordance with the ethical guidelines at the
University of Zurich and the legislation of animal care and experi-
mentation of Canton Zurich, Switzerland (ZH049/17).
Metabolic studies
Mice were individually housed in metabolic cages (UNO BV, Zeve-
naar, The Netherlands) with ad libitum drinking water and powder
food. Overnight urine collection (16 hours) was performed after 2
sessions of adaptation. To evaluate the response to NCC inhibition,
urine excreted during 6 hours after an i.p. bolus injection of HCTZ
(50 mg/gBW; Sigma) was collected and compared with urine excreted
during the same timescale after injection of vehicle (0.9 % NaCl, 10
ml/gBW). HCTZ was dissolved in 0.9% NaCl, and 10 ml per gBW was
injected for each mouse. Urine samples were centrifuged and stored
at 20C until analysis. At the end of the experiment, mice were
deeply anesthetized with an i.p. injection of ketamine (100 mg/kg
BW; Streuli Pharma AG, Uznach, Switzerland)/xylasine (20 mg/kg
BW; Streuli Pharma AG), and blood was obtained from the inferior
vena cava. Mice were then killed by cervical dislocation for organ
collection. Harvested tissue was snap-frozen in liquid nitrogen and
kept at 80C. Blood samples were centrifuged for 20 minutes at
2000  g, and serum was separated and stored at 20C.
Urine and blood chemistry
Urinary and serum Naþ and Kþ concentrations were determined by
ﬂame photometer. Urinary and serum Ca2þ, Mg2þ, Cl, and
creatinine concentrations were measured with a UniCel DxC 800
Synchron Clinical System (Beckman Coulter, Analis, sa/nv, Ville-
pinte, France) and an i-STAT analyzer (Abbott Diagnostics, Maid-
enhead, UK). Urine osmolality was measured by Osmometer (Fiske,
Needham Heights, MA).
Microdissection of renal tubules
Mouse kidneys were brieﬂy digested with type 2 collagenase as
previously described.25 Renal tubules were isolated manually ac-
cording to morphologic criteria and were lysed in the RNA lysis
buffer from the RNAqueous Total RNA Isolation Kit (Invitrogen,
Carlsbad, CA). Quantitative reverse transcription–polymerase chain
reaction was performed on pools of 70 TALs isolated as previously
described.25 When required, tweezer-assisted microdissection on
collagenase-perfused kidneys from C57BL/6J mice was performed, to
collect mTAL and cTAL enriched fractions.47
Gene expression analysis
Total RNA was extracted from isolated renal tubules with the
RNAqueous Total RNA Isolation Kit (Invitrogen) according to the
manufacturer’s protocol. DNAse I treatment was performed to
eliminate genomic DNA contamination. One microgram of RNA
was used to perform the reverse transcriptase reaction with the
iScript cDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, CA).
Changes in target genes mRNA levels were determined by relative
RT-qPCR with a CFX96 Real-Time PCR Detection System (Bio-Rad
Laboratories) using iQ SYBR Green Supermix (Bio-Rad Labora-
tories) detection of single PCR product accumulation. RT-qPCR
analyses were performed in duplicate with 100 nM of both sense
and antisense primers in a ﬁnal volume of 20 ml using iQ SYBR
Green Supermix (Bio-Rad Laboratories). Speciﬁc primers were
designed using Primer3 (Supplementary Table S2).48 PCR conditions
were 95C for 3 minutes, followed by 40 cycles of 15 seconds at 95C
and 30 seconds at 60C. The PCR products were sequenced with the
BigDye terminator kit (Perkin Elmer Applied Biosystems, Foster
City, CA). The multiScreen SEQ384 Filter Plate (Millipore, Billerica,
MA) and Sephadex G-50 DNA Grade Fine (Amersham Biosciences,
Piscataway, NJ) dye terminator removal were used to purify
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sequences reactions before analysis on an ABI3100 capillary
sequencer (Perkin Elmer Applied Biosystems).
In situ hybridization
We used RNAscope Assays (ACD Advanced Cell Diagnostics Srl,
Hayward, CA) to visualize single RNA molecules per cell in 10–20-mm
cryo-sections of the mouse kidney ﬁxed with 4% paraformaldehyde.
Sections were incubated with Probe-C3 for Umod (20ZZ probe
targeting mouse Umod, position 221-1039 of NM_009470.5), Probe-
C2 for Slc12a1 (20ZZ probe targeting mouse Slc12a1, position 1050-
2083 of NM_183354.2), and Probe-C1 for Slc12a3 (20ZZ probe
targeting mouse Slc12a3, position 516-1369 of NM_001205311.1).
Images were obtained with confocal microscope SP8 (Leica Micro-
systems, Wetzlar, Germany).
Cellular expression studies
HEK293 (ATCC, LGC Standards, Wesel, Germany) and HEK cells
stably expressing hUMOD (gift from L. Rampoldi35) were used.
HEK293 and hUMOD-expressing HEK cells were maintained in
Dulbecco’s modiﬁed Eagle’s medium high glucose with sodium py-
ruvate and glutamine (Life Technologies, Gaithersburg, MD) sup-
plemented with fetal bovine serum (10%) and antibiotics (100 mg/ml
streptomycin and 100 U/ml penicillin). The cells were grown at
37C, 5% CO2. Both cell lines were transfected with plasmid
expressing human SLC12A3 (NCC), EX-Z2925-M02 (GeneCopoeia,
Rockville, MD). Cells were placed in 450 ml of Dulbecco’s modiﬁed
Eagle’s medium, and 50 ml of polyplex (JetPEI DNA transfection
reagent; Polyplus, New York, NY) solution containing 0.5 mg of
SLC12A3 plasmid was added to the cells. Subsequent to overnight
incubation with the plasmid, the media was replaced with 0.5 ml of
complete Dulbecco’s modiﬁed Eagle’s medium, and cells were used
72 hours after transfection.
Western blot analysis
Membrane fraction protein was enriched from kidney samples as
described previously.49 HEK cells were lysed in
radioimmunoprecipitation assay buffer supplemented with
protease and phosphatase inhibitors (Roche, Basel, Switzerland) to
obtain total proteins. Samples were mixed with the Laemmli buffer
containing dithiothreitol. Forty to ﬁfty micrograms of protein were
loaded for sodium dodecylsulfate–polyacrylamide gel
electrophoresis and transferred to polyvinylidene diﬂouride
membranes. Then, membranes were blocked with 5% skim milk
or 3% bovine serum albumin in tris-buffered saline and incubated
with rabbit anti-NCC (1:1000; Millipore), -pT53 or pT58 NCC
(1:5000, previously characterized50), rabbit anti-phospho SPAK
(Ser373)/phospho OSR1 (Ser325) (07-2273, 1:500; Millipore),
rabbit anti-SPAK (07-2271, 1:1000; Millipore), or rabbit anti-OSR1
(07-2264, 1:500; Millipore) antibody overnight at 4C. Membrane
was washed with tris-buffered saline and incubated with
horseradish peroxidase–conjugated rabbit IgG (1:10000; Dako,
Carpinteria, CA), and signals were revealed with the ChemiDoc
imaging system (Bio-Rad Laboratories). The protein expression
was normalized with the signal obtained with ﬂottilin-1 or b-actin
expression.
Immunoﬂuorescent analysis
Left kidneys were perfused and ﬁxed with 4% paraformaldehyde/
phosphate-buffered saline and processed in parafﬁn. Four-
micrometer-thick parafﬁn sections were heated at 95C for 10
minutes in 10 mM Na-citrate (pH 6.0) for antigen retrieval and
followed by a blocking step with a solution containing 3% bovine
serum albumin, 0.05% Tween-20, 50 mM glycine, and 50 mM
NH4Cl in phosphate-buffered saline. Then sections were incubated
with sheep anti-uromodulin (1:500; Meridian, Memphis, TN), rabbit
anti-NCC (1:500; Millipore), pT53 NCC (1:1000, previously char-
acterized50), TRPV5 (1:500, a gift from O. Bonny), phospho SPAK
(Ser373)/phospho OSR1 (Ser325)(07-2273, 1:300; Millipore), or
mouse anti-parvalbumin (1:500; Swant, Marly, Switzerland) anti-
bodies, overnight at 4 C. After washing steps, sections were incu-
bated with ﬂuorescein-conjugated secondary antibodies (1:500;
Invitrogen) for 1 hour at room temperature. Sections were mounted
in ProLong Gold antifade mounting medium (Invitrogen), and
images were aquired with a confocal microscope (Leica SP5 or SP8).
Quantiﬁcation of ﬂuorescence intensity and renal fractional
volume
Quantiﬁcation of T53 pNCC immunoﬂuorescent intensity was per-
fomed on kidney sections costained for T53 pNCC and parvalbumin
to distinguish between DCT1 (T53 pNCC-positive; parvalbumin-
positive) and DCT2 (T53 pNCC-positive; parvalbumin-negative). A
series of pictures (at least 5) from at least 3 different mice were ac-
quired using a confocal microscope (Leica Microsystems) and a 40
oil immersion objective, with parameters kept unchanged. Using
ImageJ software,51 a threshold was set to select all the stained area, and
all T53 pNCC-positive tubules were outlined, assigned as DCT1 or
DCT2. The intensity of each tubule was calculated from division of
integrated signal density within the tubule by tubular area. Tubules at
the border of the picture were excluded.34
Renal fractional volume occupied by DCT1 and DCT2 was
assessed in the same T53 pNCC/parvalbumin costained kidney
sections. A series of low-magniﬁcation pictures (6–9) from at least 2
different mice was acquired using a confocal microscope (Leica
Microsystems) and a 10 objective, with parameters kept un-
changed. Using ImageJ software,51 all T53 pNCC-positive tubules
were outlined, assigned as DCT1 or DCT2, and their combined area
quantiﬁed. Then the area of the corresponding total kidney section
was determined and used as a normalization factor.34
Statistics
Data are presented as means  SEM. Two-tailed unpaired and paired
Student’s t tests were used for statistical analysis, as indicated, and a P
value of <0.05 was considered signiﬁcant.
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